Comparative audit of pergolide and cabergoline therapy in the treatment of nocturnal 'off' periods causing sleep disruption in Parkinson's disease

被引：0
|
作者：
Ghatani, T
Agapito, C
Bhattacharya, KF
Clough, C
Chaudhuri, KR
机构：
[1] Kings Coll Hosp London, Reg Movement Disorders Autonom Unit, London, England
[2] Guys Kings & St Thomas Med Sch, London, England
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2001年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：8 / 11
页数：4
相关论文
共 18 条
  • [1] Sleep and motor performance in patients with Parkinson's disease after initiation of treatment with cabergoline
    Trenkwalder, CM
    Rothdach, A
    Wetter, TC
    Hoegl, B
    NEUROLOGY, 2000, 54 (07) : A32 - A32
  • [2] A levodopa dry powder inhaler for the treatment of Parkinson's disease patients in off periods
    Luinstra, Marianne
    Grasmeijer, Floris
    Hagedoorn, Paul
    Moes, Jan Reindert
    Frijlink, Henderik W.
    de Boer, Anne H.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 97 : 22 - 29
  • [3] Nocturnal Sleep Problems Mediate the Impact on Quality of Life of Early Morning Off in Parkinson's Disease
    Zhang, Yu
    Zhang, Zi En
    Shi, De
    Zhao, Yi
    Huang, Lihong
    Zhao, Yanxin
    Wang, Hui
    Zhao, Jing
    Wang, Feng
    Zhao, Chaorong
    Gao, Shan
    Wei, Wenshi
    Huang, Dongya
    Liu, Zhen Guo
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [4] Does good sleep reduce early-morning off periods in patients with Parkinson's disease?
    Suzuki, Keisuke
    Fujita, Hiroaki
    Okamura, Madoka
    Kobayashi, Saro
    Hirata, Koichi
    SLEEP, 2020, 43 (08)
  • [5] A novel levodopa dry powder inhaler for treatment of off periods in Parkinson's disease patients
    Luinstra, M.
    Grasmeijer, F.
    Hagedoorn, P.
    Frijlink, H. W.
    de Boer, A. H.
    MOVEMENT DISORDERS, 2015, 30 : S427 - S427
  • [6] Cabergoline versus pergolide in levodopa-treated Parkinson's disease patients with nocturnal disabilities: A randomised, double-blind crossover trial to evaluate efficacy, tolerability, and quality of life
    Trenkwalder, C
    Canelo, M
    Forbes, A
    Leroux, M
    Chaudhuri, KR
    MOVEMENT DISORDERS, 2004, 19 : S267 - S267
  • [7] Rapid treatment of "off" episodes - Will this change Parkinson's disease therapy? Introduction
    Stacy, M
    Factor, S
    NEUROLOGY, 2004, 62 (06) : S1 - S2
  • [8] Efficacy of CVT-301 (levodopa inhalation powder) for treatment of OFF periods in Parkinson's disease
    Pahwa, R.
    Abeynayake, I.
    Klingler, M.
    Sedkov, A.
    Kenney, C.
    Oh, C.
    MOVEMENT DISORDERS, 2018, 33 : S164 - S164
  • [9] Early morning off periods in Parkinson's disease: Characterisation of non motor patterns and treatment effect: An international study
    Rizos, A.
    Kessel, B.
    Martinez-Martin, P.
    Odin, P.
    Antonini, A.
    Martin, A.
    Koch, I.
    Kozul, T. Klemencic
    Reddy, P.
    Robinson, S.
    Falup-Pecurariu, C.
    Douiri, A.
    Lindvall, S.
    Chaudhuri, K. Ray
    MOVEMENT DISORDERS, 2012, 27 : S519 - S519
  • [10] Inhaled levodopa (CVT-301) for treatment of OFF periods in Parkinson's disease: efficacy as assessed by 39-item Parkinson's Disease Quality of Life (QoL) Questionnaire
    LeWitt, P.
    Hauser, R. A.
    Oh, C.
    Qian, J.
    Kenney, C.
    Abeynayake, I.
    MOVEMENT DISORDERS, 2019, 34 : S7 - S8
12